Editorial Board
EDITORS
Steven V. Edelman, MD
University of California San Diego
San Diego, CA
Steven V. Edelman, MD is a Professor of Medicine in the Division of Endocrinology and Metabolism at the University of California, San Diego. He also serves as Director of the Diabetes Care Clinic at the Veterans Affairs Medical Center in San Diego.
Dr. Edelman received his medical degree from the University of California, Davis. His postgraduate training included a residency in internal medicine at University of California, Los Angeles - San Fernando, a clinical fellowship in diabetes and metabolism at The Joslin Clinic, a fellowship in endocrinology and metabolism at the Lahey Clinic in Burlington, Massachusetts, and a research fellowship in diabetes and metabolism at the University of California, San Diego. Dr. Edelman is certified in internal medicine and metabolism, diabetes, and endocrinology.
Dr. Edelman is the Founder and Director of Taking Control of Your Diabetes, a series of educational and motivational conferences and health fairs for people living with diabetes. He serves as a reviewer for several scientific journals. He has written two books and published more than 100 articles and abstracts relating to diabetes care.
Derek LeRoith, MD, PhD
Mount Sinai School of Medicine
New York, NY
Derek LeRoith, MD, PhD, is an endocrinologist and diabetologist, serving on the faculty of the Division of Endocrinology and Diabetes at the Mount Sinai School of Medicine in New York City.
Dr. LeRoith received his medical education in Cape Town, South Africa, with senior residency training at The Middlesex Hospital in London, England. He has extensive experience in diabetes research, working for two decades in various positions at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH), based in Bethesda, Maryland. He was a member of the faculty of the University of Cincinnati College of Medicine and implemented several diabetes teaching and clinical programs in the greater Cincinnati, Ohio, region.
In addition to his leadership roles (including previous service on the national board of the American Diabetes Association and his work with the Endocrine Fellows Foundation), Dr. LeRoith serves on the editorial boards for several scientific journals and is a consultant for many healthcare organizations and pharmaceutical companies. Dr. LeRoith has published more than 500 original research papers, reviews, and editorials. He has edited several books on diabetes, including medical textbooks.
Editorial Board
Anuj Bhargava, MD, MBA, CDE, FACP, FACE
Endocrinology
Iowa Diabetes and Endocrinology Center
Des Moines, IA
Nancy J.V. Bohannon, MD
Clinical Diabetes
Monteagle Medical Center
San Francisco, CA
A. Enrique Caballero, MD
Endocrinology & Metabolism
Joslin Diabetes Center
Boston, MA
Carlos Campos, MD, MPH
Family Medicine/Public Health
Private Practice
New Braunfels, TX
William Cefalu, MD
Internal Medicine/Endocrinology & Metabolism
Louisiana State University
Baton Rouge, LA
Stephen Clement, MD
Endocrinology/Diabetes
Georgetown University Hospital
Washington, DC
Sheri Colberg-Ochs, PhD
Exercise Physiology
Old Dominion University
Norfolk, VA
Thomas Flood, MD
Diabetes
Georgia Center for Diabetes
Atlanta, GA
James R. Gavin III, MD, PhD
Endocrinology
Emory University School of Medicine
Atlanta, GA
Linda B. Haas, RN, PhC, CDE
Endocrinology
VA Puget Sound Health Care System
Seattle, WA
John W. Hare, MD
Internal Medicine/Endocrinology & Metabolism
Joslin Diabetes Center
Boston, MA
Paul S. Jellinger, MD
Endocrinology/Diabetes
University of Miami School of Medicine
Miami, FL
Sandra Leal, PharmD, CDE
Clinical Pharmacy
El Rio Health Center
Tucson, AZ
Jack L. Leahy, MD
Endocrinology
University of Vermont
Burlington, VT
Scott E. Nelson, MD
Family Medicine
Cleveland Family Medicine
Cleveland, MS
Timothy S. Reid, MD
Family Medicine/Diabetes
Mercy Diabetes Center
Janesville, WI
Susan M. Renda, MS, CRNP, CDE
Primary Care/Diabetes
Clinical Associates
Reisterstown, MD
Charles Shaefer, Jr, MD
Internal Medicine
University Primary Care Physicians
Augusta, GA
Linda Siminerio, PhD, CDE
Diabetes
University of Pittsburgh Medical Center
Pittsburgh, PA
Leonel Villa-Caballero, MD, PhD
Internal Medicine & Metabolism/Public Health/
Cross-Cultural & International Medicine
University of California, San Diego
La Jolla, CA
Aaron I. Vinik, MD, PhD
Endocrinology
Eastern Virginia Medical School
Norfolk, VA
Russell D. White, MD
Family Medicine
University of Missouri
Kansas City, MO
Editors
Acknowledgements
Dr. Anuj Bhargava—Speakers’ Bureau: Novo Nordisk A/S, sanofi-aventis U.S., Pfizer, Inc., Amylin Pharmaceuticals, Inc., Abbott Laboratories, Takeda Pharmaceuticals, Merck & Co., Inc.; Research Support: Novo Nordisk, Pfizer, Amylin, Eli Lilly and Company, Merck.
Dr. Nancy Bohannon—Consultant, Speaker, and Advisory Board Member: Eli Lilly and Company, Pfizer, Novartis Pharmaceuticals, sanofi-aventis, Vivus, Amylin, Merck, Takeda.
Dr. A. Enrique Caballero—Speakers’ Bureau and Advisory Board: Amylin, Eli Lilly and Company, sanofi-aventis, Takeda Pharmaceuticals North America, Inc.; Advisory Board: Pfizer.
Dr. Carlos Campos—No financial relationships with commercial interests.
Dr. William Cefalu—Grant Support: Pfizer, Merck, Eli Lilly and Company, Novartis; Advisory Board: Pfizer, Merck, Eli Lilly and Company.
Dr. Stephen Clement—No financial relationships with commercial interests.
Dr. Sheri Colberg-Ochs—No financial relationships with commercial interests.
Dr. Thomas Flood—Honoraria and Speakers’ Bureau: sanofi-aventis, GlaxoSmithKline, Merck, Pfizer.
Dr. James R. Gavin, III—Consultant: GlaxoSmithKline, Merck, Eli Lilly and Company, sanofi-aventis, Novartis, LifeScan, Inc., Takeda; Speakers’ Bureau: Eli Lilly and Company; Director: Amylin.
Dr. Linda Haas—Advisory Board: sanofi-aventis; Stockholder: Amylin.
Dr. John W. Hare—Advisory Board: LifeScan.
Dr. Paul S. Jellinger—No financial relationships with commercial interests.
Dr. Jack L. Leahy—Consultant and Speakers’ Bureau: Merck, sanofi-aventis.
Dr. Sandra Leal—No financial relationships with commercial interests.
Dr. Scott E. Nelson—Consultant: sanofi-aventis.
Dr. Timothy S. Reid—Speakers’ Bureau and Advisory Board: Amylin, Bayer AG, GlaxoSmithKline, Medtronic Minimed, Inc., Novartis, Novo Nordisk, Pfizer, sanofi-aventis.
Dr. Susan M. Renda—Speaker and Honoraria: Bayer, sanofi-aventis, Amylin, Eli Lilly and Company.
Dr. Charles Shaefer, Jr. —Speakers’ Bureau: Takeda Pharmaceuticals, Daiichi-Sankyo; Speaker: sanofi-aventis, Pfizer.
Dr. Linda Siminerio—Advisory Board: Eli Lilly and Company, Novo Nordisk, Becton, Dickinson and Company, General Mills, Takeda; Speaker: Amylin, Merck, sanofi-aventis.
Dr. Leonel Villa-Caballero—No financial relationships with commercial interests.
Dr. Aaron I. Vinik—Consultant and Speakers’ Bureau: Pfizer, Merck, Eli Lilly and Company, Bristol-Myers Squibb, Novartis, GlaxoSmithKline, Neurometrix, R.W. Johnson Pharmaceutical Research Institute, Takeda, AstraZeneca, NeurogesX, sanofi-aventis, Medco Health Solutions, Inc., Regeneron Pharmaceuticals, Inc., DLife, Health ABC, Mitsubishi Pharma America, Inc., Theratechnologies, Inc., Fujisawa Healthcare Inc., Paramount Biosciences, LLC; Grant Support: GMP-Endotherapeutics, American Diabetes Association, Eli Lilly and Company, Park Davis, ASTA Medica, SmithKline Beecham Pharmaceuticals, National Institute of Aging, Lilly Research Laboratories, Merck, Robert Wood JohnsonUniversity Hospital, Quintiles Transnational Corporation, National Institutes of Health, Hoechst Marion Roussel, Inc., ASTA Medica AG, Juvenile Diabetes Research Foundation International, Takeda Pharmaceuticals North America, Inc., United States Department of Health & Human Services, PPD Development, Dyansys, Inc., Private Donor Grant, AstraZeneca, Dainippon Pharmaceutical Co., Ltd., Pliva d.d., Mallinckrodt, Inc., Commonwealth Research Board, Old Dominion University Research Foundation, Medpace, Inc.
Dr. Russell D. White—Speakers’ Bureau: American Academy of Family Physicians, American Diabetes Association, University of Missouri-Kansas City School of Medicine, The National Procedures Institute; Consultant: Novo Nordisk.
